R. / Brent / Washington / D. C. / Matassova / New York / Paris / Kingston / Hendges / Kalamazoo / Andersen / San Diego / /
Company
L. Xiong A. S. / Kodak / Mankin A. S. / Eastman Kodak Co. / Garmon S. A. / Chichkova N. V. / Molecular Biology Inc. / Oxford University Press / John Wiley & Sons Inc. / Carrier / Wilson / Ford / Pharmacia Corp. / Covance / Bio-Rad / Garrett / Dahlberg A. E. / /
Continent
America / /
Country
United States / / /
Event
FDA Phase / /
Facility
University of Illinois / N terminus of L27 / To bridge / N terminus / /
IndustryTerm
active site / putative site / peptidyltransferase active site / drug binding site / affinity oxazolidinone binding site / energy exposure / oxazolidinone binding site / pharmacophoric oxazolidinone / in-house server / azido / /
MedicalCondition
strain / MS / intact S. aureus / S. aureus / /
MedicalTreatment
antibiotics / /
Organization
Center for Pharmaceutical Biotechnology / American Society for Microbiology / University of Illinois / Chicago / Oxford University / American Society for Biochemistry / /
Person
Liqun Xiong / Gary Zurenko / Mark McCroskey / John E. Mott / Eric T. Cecil / Eric T. Lund / Daniel J. Waldon / John Chosay / James D. Pearson / Jerry R. Colca / Dean L. Shinabarger / Jeffrey H. Bock / Lisa M. Thomasco / James Blinn / William G. McDonald / Robert C. Gadwood / Nano / Alexander S. Mankin / Lonnie D. Adams / Sara Morin / Gregory S. Cavey / W. Rodney Mathews / / /